Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASP3550 Phase II Study - A Maintenance-Dose-Finding Study of Three-Month Depot in Patients With Prostate Cancer -

NCT01261572 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01261572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01261572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASP3550 Phase II Study - A Maintenance-Dose-Finding Study of Three-Month Depot in Patients With Prostate Cancer -
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
October 12, 2010
Completion date
April 24, 2012
Enrollment
155 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms